Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport.
about
Treatment with proteasome inhibitor bortezomib decreases organic anion transporting polypeptide (OATP) 1B3-mediated transport in a substrate-dependent manner.Gaining mechanistic insight into coproporphyrin I as endogenous biomarker for OATP1B-mediated drug-drug interactions using population pharmacokinetic modelling and simulation.Prediction of drug-drug interaction potential using physiologically based pharmacokinetic modeling.Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues.Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions.
P2860
Pretreatment With Rifampicin and Tyrosine Kinase Inhibitor Dasatinib Potentiates the Inhibitory Effects Toward OATP1B1- and OATP1B3-Mediated Transport.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pretreatment With Rifampicin a ...... nd OATP1B3-Mediated Transport.
@en
type
label
Pretreatment With Rifampicin a ...... nd OATP1B3-Mediated Transport.
@en
prefLabel
Pretreatment With Rifampicin a ...... nd OATP1B3-Mediated Transport.
@en
P2093
P2860
P1476
Pretreatment With Rifampicin a ...... and OATP1B3-Mediated Transport
@en
P2093
Alexandra Crowe
Khondoker Alam
Oliver Hatley
Sonia Pahwa
Taleah Farasyn
P2860
P304
P356
10.1016/J.XPHS.2017.03.022
P407
P577
2017-04-01T00:00:00Z